Mechanisms of cancer-associated glycosylation changes

被引:119
作者
Dall'Olio, Fabio [1 ]
Malagolini, Nadia [1 ]
Trinchera, Marco [2 ]
Chiricolo, Mariella [1 ]
机构
[1] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[2] Univ Insubria, Dept Biomed Sci Expt & Clin DSBSC, I-21100 Varese, Italy
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2012年 / 17卷
关键词
Glycosylation; Glycosyltransferases; Sialyl Lewis Antigens; Thomsen-Friedenreich Antigen; Gangliosides; Selectins; Galectins; Review; HUMAN COLON-CANCER; SIALYL-LEWIS-X; N-ACETYLGLUCOSAMINYLTRANSFERASE-V; THOMSEN-FRIEDENREICH ANTIGEN; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; MESSENGER-RNA EXPRESSION; GD3 SYNTHASE GENE; GROWTH-FACTOR RECEPTOR; CORE 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; ALPHA-2,6 SIALYLTRANSFERASE ACTIVITY;
D O I
10.2741/3951
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell membrane glycoconjugates undergo characteristic changes as a consequence of neoplastic transformation. The cancer-associated carbohydrate structures play key roles in cancer progression by altering the cell-cell and cell-environment interactions. In this review, we will discuss some of the most relevant cancer-associated carbohydrate structures, including the beta 1,6-branching of N-linked chains, the sialyl Lewis antigens, the alpha 2,6-sialylated lactosamine, the Thomsen-Friedenreich-related antigens and gangliosides. We will describe the mechanisms leading to the expression of these structures and their interactions with sugar binding molecules, such as selectins and galectins. Finally, we will discuss how the glycosylation machinery of the cell is controlled by signal transduction pathways, epigenetic mechanisms and responds to hypoxia.
引用
收藏
页码:670 / 699
页数:30
相关论文
共 354 条
[81]   The sweet and sour of cancer: Glycans as novel therapeutic targets [J].
Fuster, MM ;
Esko, JD .
NATURE REVIEWS CANCER, 2005, 5 (07) :526-542
[82]   Differential expression of α2,6-sialyltransferase in colon tumors recognized by a monoclonal antibody [J].
Gangopadhyay, A ;
Perera, SP ;
Thomas, P .
HYBRIDOMA, 1998, 17 (02) :117-123
[83]   Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma [J].
Gao, S ;
Worm, J ;
Guldberg, P ;
Eiberg, H ;
Krogdahl, A ;
Liu, CJ ;
Reibel, J ;
Dabelsteen, E .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (02) :230-237
[84]   Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling [J].
Garner, Omai B. ;
Baum, Linda G. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 :1472-1477
[85]   ENHANCED ACTIVITY OF CMP-NEUAC-GAL-BETA-1-4GLCNAC-ALPHA-2,6-SIALYLTRANSFERASE IN METASTASIZING HUMAN COLORECTAL TUMOR-TISSUE AND SERUM OF TUMOR PATIENTS [J].
GESSNER, P ;
RIEDL, S ;
QUENTMAIER, A ;
KEMMNER, W .
CANCER LETTERS, 1993, 75 (03) :143-149
[86]   Epigenetic reprogramming of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) in HIV-1-infected CEM T cells [J].
Giordanengo, V ;
Ollier, L ;
Lanteri, M ;
Lesimple, J ;
March, D ;
Thyss, S ;
Lefebvre, JC .
FASEB JOURNAL, 2004, 18 (13) :1961-+
[87]   Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells [J].
Glinskii, OV ;
Turk, JR ;
Pienta, KJ ;
Huxley, VH ;
Glinsky, VV .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 554 (01) :89-99
[88]  
Glinsky VV, 2001, CANCER RES, V61, P4851
[89]  
Glinsky VV, 2000, CANCER RES, V60, P2584
[90]  
Granovsky M, 2000, NAT MED, V6, P306